BONOTTO, Marta
 Distribuzione geografica
Continente #
NA - Nord America 396
EU - Europa 93
AS - Asia 21
AF - Africa 2
SA - Sud America 1
Totale 513
Nazione #
US - Stati Uniti d'America 393
IT - Italia 46
DE - Germania 16
VN - Vietnam 16
FR - Francia 14
SE - Svezia 10
CA - Canada 3
CN - Cina 3
FI - Finlandia 2
GB - Regno Unito 2
RU - Federazione Russa 2
ZA - Sudafrica 2
CL - Cile 1
IN - India 1
TW - Taiwan 1
UA - Ucraina 1
Totale 513
Città #
Fairfield 38
Woodbridge 34
Ashburn 33
Columbus 33
Santa Cruz 32
Seattle 24
Houston 22
Buffalo 20
Dong Ket 16
Udine 14
Wilmington 13
Cambridge 12
Des Moines 10
Stockholm 10
Gorizia 9
Ann Arbor 7
Las Vegas 7
Chicago 6
San Diego 5
Clearwater 4
Auburn 3
Dallas 3
Riva 3
University Park 3
Beijing 2
Büdelsdorf 2
Helsinki 2
Henderson 2
Leatherhead 2
Los Angeles 2
Montereale Valcellina 2
Muizenberg 2
Ottawa 2
Phoenix 2
Venezia 2
Venice 2
Arba 1
Azzano Decimo 1
Bassano del Grappa 1
Berlin 1
Böblingen 1
Charlotte 1
Crugers 1
Easton 1
Falkenstein 1
Gunzenhausen 1
Hillsboro 1
Melfi 1
Milan 1
Mumbai 1
Nanning 1
New York 1
Paris 1
Polcenigo 1
Provo 1
Reston 1
Sagrado 1
San Francisco 1
Scottsdale 1
Sindelfingen 1
Taipei 1
Toronto 1
Trieste 1
Totale 412
Nome #
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis, file e27ce0c4-fa92-055e-e053-6605fe0a7873 127
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer, file e27ce0c9-432f-055e-e053-6605fe0a7873 96
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA), file e27ce0c7-5355-055e-e053-6605fe0a7873 94
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer, file e27ce0c7-af22-055e-e053-6605fe0a7873 90
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients, file e27ce0c7-7d6f-055e-e053-6605fe0a7873 78
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis, file e27ce0c8-be18-055e-e053-6605fe0a7873 24
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study, file e27ce0c8-cdd2-055e-e053-6605fe0a7873 22
Measures of outcome in metastatic breast cancer: insights from a real-world scenario., file e27ce0c3-2c69-055e-e053-6605fe0a7873 1
Looking for predictive markers in breast cancer, file e27ce0c3-306e-055e-e053-6605fe0a7873 1
[Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?], file e27ce0c3-3799-055e-e053-6605fe0a7873 1
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival, file e27ce0c8-87ed-055e-e053-6605fe0a7873 1
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use, file e27ce0c8-c49f-055e-e053-6605fe0a7873 1
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey, file e27ce0c8-c73f-055e-e053-6605fe0a7873 1
Totale 537
Categoria #
all - tutte 1.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 8 5
2019/202071 4 4 2 4 2 3 3 2 9 11 18 9
2020/2021142 4 7 10 22 13 16 6 14 5 17 8 20
2021/2022111 6 11 0 10 9 1 8 7 1 9 38 11
2022/2023105 0 5 33 13 6 22 1 3 6 5 9 2
2023/202484 4 0 11 1 12 10 1 9 0 0 36 0
Totale 537